Development of Smart Insulin Delivery Systems for Improving Diabetes Management in Public Health

The rising global prevalence of Type 1 and Type 2 diabetes presents significant challenges to healthcare systems worldwide, necessitating innovative solutions for more effective management. This paper explores the development of smart insulin delivery systems, which utilize advanced technologies such as continuous glucose monitoring (CGM) and automated insulin delivery to optimize diabetes management. These systems hold promise for improving glycemic control, reducing the risk of complications, and enhancing patient outcomes. This study reviews current insulin delivery methods, investigates emerging smart insulin technologies, and analyzes the challenges and barriers to their widespread adoption. The paper highlights the potential of closed-loop insulin delivery systems, biosensors, and artificial pancreas systems in transforming diabetes care. Despite the substantial promise, several challenges remain, including technical limitations, cost implications, patient adherence, regulatory hurdles, and issues related to access in underserved populations. Additionally, the integration of these systems into existing healthcare infrastructure, particularly in low-resource settings, is a significant concern. The findings suggest that smart insulin delivery systems have the potential to revolutionize diabetes care, providing personalized, automated insulin delivery that could lead to better disease management and reduced healthcare costs. Future research should focus on improving sensor accuracy, enhancing system integration with mobile health applications, and exploring scalability across diverse populations. This paper underscores the need for policy support, funding, and strategic innovation to ensure that these technologies are accessible and effective in addressing the global diabetes epidemic.